Free · 13,587 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Other

Effects of Vascular Photobiomodulation on Glycemic Control in Patients With Type II Diabetes Mellitus: A Prospective Single-Arm Clinical Study

Systemic application of low-level laser therapy through the vascular technique, combined with standard oral hypoglycemic therapy, may contribute to improved glycemic control in individuals with T2DM.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors studied 6 weeks of vascular photobiomodulation, a red laser applied over the radial artery, in people with type 2 diabetes already taking metformin. They report acute drops in capillary blood glucose after sessions and a fall in fasting plasma glucose, but no significant change in HbA1c or systolic blood pressure. The single-arm design without a control group limits how strongly these findings can be interpreted.

Who or what was studied
Adults with type 2 diabetes mellitus receiving continuous metformin (500 mg to 850 mg) for at least 6 months, in Palmas, Tocantins, Brazil
Limits stated in the abstract
The prospective single-arm design has no control group and the abstract does not state the number of participants.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Objective

This study aimed to evaluate the effects of laser photobiomodulation (PBM) using the systemic vascular technique (VPBM) on glycemic control in individuals with type 2 diabetes mellitus (T2DM) undergoing conventional pharmacological treatment.

Methods

This prospective single-arm clinical study was conducted at Centro Universitário UNITOP, in Palmas, Tocantins, Brazil. Individuals diagnosed with T2DM who had been receiving continuous oral hypoglycemic therapy with metformin (500 mg to 850 mg) for at least 6 months were included. PBM was applied transcutaneously over the radial artery using a low-level laser device emitting red light, aiming to promote systemic vascular irradiation. Capillary blood glucose levels were monitored through self-monitoring, while fasting plasma glucose and glycated hemoglobin (HbA1c) levels were analyzed in a certified clinical laboratory throughout the follow-up period.

Results

In type 2 diabetes patients, VPBM induced significant acute reductions in capillary blood glucose immediately after all sessions (from averages over 180-220 mg/dL down to 119-129 mg/dL; p ≤ 0.0019). It also significantly lowered baseline fasting blood glucose over the 6-week protocol from 161.40 ± 32.63 mg/dL to 130.40 + 37.62 mg/dL (p = 0.0339). However, it showed no statistically significant effects on HbA1c: 7.61% to 7.65% or systolic blood pressure.

Conclusion

Systemic application of low-level laser therapy through the vascular technique, combined with standard oral hypoglycemic therapy, may contribute to improved glycemic control in individuals with T2DM. PBM associated with VPBM appears to represent a promising complementary therapeutic strategy for metabolic management in this population.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Laser, Low-level laser therapy. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies